MIV-711 not associated with pain reduction, but may reduce disease progression in osteoarthritis

1. MIV-711 not associated with pain reduction, but may reduce disease progression in osteoarthritis Abstract: http://annals. org/ aim/ article/ doi/ 10. 7326/ M19-0675 Editorial: http://annals. org/ aim/ article/ doi/ 10. 7326/ M19-3809 URLs go live when the embargo lifts MIV-711,…

Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice

Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast cancer development in the offspring whose mothers had not been fed a high fat diet during pregnancy.

First study to compare citrus varieties with combination of metabolomics and microbiome

Citrus greening disease, or Huanglongbing (HLB), is deadly, incurable, and the most significant threat to the citrus industry. Most HLB research focuses on the tree canopy, but scientists in California studied the impact of HLB on root systems. They recently…

NUS and A*STAR scientists identify promising liver cancer-killing compounds with novel drug-screening platform

Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)’s Genome Institute of Singapore (GIS) have discovered four potential drug compounds that target hepatocellular carcinoma (HCC), the most common type of liver cancer.

Proton therapy as effective as standard radiation with fewer side effects

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania.

Closing of Second Antibiotic Company Highlights Urgent Need for Investment in Infection Fighting Drugs

The bankruptcy announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs. Melinta is the second antibiotic company this year forced into bankruptcy because it could not make a sufficient return on its investment in medicines that are urgently needed to protect individual and public health and national security. Melinta’s bankruptcy puts into jeopardy the continued availability of its four antibiotics — lifesaving tools that patients cannot afford to lose given our already limited antibiotic arsenal.

Researchers identify new therapeutic target for colorectal cancer

Researchers at the University of Toronto have identified a key protein that supports the growth of many colorectal cancers. The study, which will be published December 27 in the Journal of Cell Biology, reveals that a protein called Importin-11 transports the cancer-causing protein βcatenin into the nucleus of colon cancer cells, where it can drive cell proliferation. Inhibiting this transport step could block the growth of most colorectal cancers caused by elevated βcatenin levels.

Children born preterm are more likely to be placed outside the home

Children born prematurely, i.e. before week 37, are more likely to be placed outside the home as a supportive child welfare measure than their full-term counterparts, according to a population study conducted by the Finnish Institute for Health and Welfare…

Which of these mushrooms could kill you? (video)

WASHINGTON, Dec. 27, 2019 — There are tens of thousands of mushroom species out there, and some of them could kill you. Today we’re going to test how well you can separate the perfectly safe from the perilously poisonous, and…

NASA finds an elongated Phanfone now a tropical storm

NASA-NOAA’s Suomi NPP satellite provided a visible image of Phanfone as it continues moving through the South China Sea. Visible imagery showed that the storm is less organized and elongated as the storm weakened from a typhoon to a tropical…

Targeting cholesterol metabolism in macrophages to eliminate viral infection

Recent evidence suggests a link between cholesterol metabolism and innate immunity. Upon viral infection, macrophages show reduced cholesterol synthesis accompanied by enhanced expression of antiviral genes, including type I interferon (IFN-I). IFN-I can induce 25-hydroxycholesterol (25-HC) accumulation, which blocks viral…

NASA finds heavy rain potential in tropical storm Sarai

NASA analyzed the cloud top temperatures in Tropical Storm Sarai using infrared light to determine the strength of the storm. Sarai has triggered warnings for Fiji and Tonga in the Southern Pacific Ocean, On Dec. 27, there are regional warnings…

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug in

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug interactions in patients coinfected with HIV/HCV is presented in The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug in

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug interactions in patients coinfected with HIV/HCV is presented in The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

‘Nipple By Number’ Device Helps Plastic Surgeons Perform 3D Nipple Tattoos

Three-dimensional tattoos offer a new alternative for creating a natural-looking nipple after breast reconstruction. For most women, accessing this option means finding a tattoo artist with the skill to create these detailed tattoos. Now a new device called Nipple By Number® enables plastic surgeons to perform realistic-looking 3D nipple tattoos as an in-office procedure, reports a paper in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Yale Cancer Center launches Center for Community Engagement and Health Equity

Yale Cancer Center (YCC) announces the launch of the Center for Community Engagement and Health Equity (CEHE). Building on YCC’s longstanding commitment to high-quality, expert, and patient-centered cancer care, screening, and prevention across the state of Connecticut, the new Center is dedicated to ensuring cancer health equity and improving outcomes with an emphasis on traditionally underserved neighborhoods.

Brain Tumor Organoids May be Key to Time-sensitive Treatments for Glioblastomas

Lab-grown brain organoids developed from a patient’s own glioblastoma, the most aggressive and common form of brain cancer, may hold the answers on how to best treat it. A new study in Cell from researchers at Penn Medicine showed how glioblastoma organoids could serve as effective models to rapidly test personalized treatment strategies.